Evidence map›Paper›PMID 32221821›Full record

ArticleJournal of microbiology (Seoul, Korea)2020

Rapid determination of carbapenem resistance by low-cost colorimetric methods: Propidium Iodide and alamar blue staining.

Jiyoon Choi, Jiwon Baek, Daehyuk Kweon, Kwan Soo Ko, Hyunjin Yoon

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of microbiology (Seoul, Korea), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Rapid Determination of Antibiotic Resistance inFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jiyoon ChoiDepartment of Molecular Science and Technology, Ajou University, Suwon, 16499, Republic of Korea.
Jiwon BaekDepartment of Molecular Science and Technology, Ajou University, Suwon, 16499, Republic of Korea.
Daehyuk KweonDepartment of Genetic Engineering and Center for Human Interface Nano Technology, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Kwan Soo KoDepartment of Molecular Cell Biology, Sungkyunkwan University, School of Medicine, Suwon, 16419, Republic of Korea.
Hyunjin YoonDepartment of Molecular Science and Technology, Ajou University, Suwon, 16499, Republic of Korea. yoonh@ajou.ac.kr.
Ajou University · KRSungkyunkwan University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenems are a class of β-lactam antibiotics with a broad antimicrobial activity spectrum. Owing to their sturdy structures resistant to most β-lactamases, they have been regarded as one of the last-resort antibiotics for combating multidrugresistant bacterial infections. However, the emergence of carbapenem resistance increases predominantly in nosocomial pathogens. To prevent spread of carbapenem resistance in early stages, it is imperative to develop rapid diagnostic tests that will substantially reduce the time and cost in determining carbapenem resistance. Thus, we devised a staining-based diagnostic method applicable to three different Gram-negative pathogens of Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae, all with the high potential to develop carbapenem resistance. Regardless of the resistance mechanisms presented by bacterial species and strains, double staining with propidium iodide (PI) and alamar blue (AB) identified resistant bacteria with an average sensitivity of 95.35%, 7 h after imipenem treatments in 343 clinical isolates. Among the three species tested, A. baumannii showed the highest diagnostic sensitivity of 98.46%. The PI and ABmediated staining method could be a promising diagnostic method with high-throughput efficacy and low cost.

Indexed as

beta-Lactam ResistanceColorimetryGram-Negative BacteriaHumansOxazinesPropidiumStaining and LabelingXanthenesOxazinesPropidiumresazurinXanthenesalamar bluecarbapenemGram-negative pathogenpropidium iodideresistance

Identifiers

PMID32221821
OpenAlexW3013231484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.